Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Kobayashi

Showing results (281-290 of 380) with videos related to

Pageof 38
Sort By:
Surgical Case Reports|May 21, 2026
Upfront Cytoreductive Surgery as a Bridge to Systemic Therapy for Recurrent Peritoneal Dissemination of Ovarian Angiosarcoma: A Pediatric Case ReportMasanaga Matsumoto, Takato Sasaki, Yudai Goto, et al.
International Journal of Clinical Oncology|October 14, 2021
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patientsNaomi Iwasa-Inoue, Hiroyuki Nomura, Fumio Kataoka, et al.
Journal of Gynecologic Oncology|June 17, 2022
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosisTakayuki Takahashi, Hikaru Matsuoka, Rieko Sakurai, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian CancerYusuke Kobayashi, Takashi Takeda, Haruko Kunitomi, et al.
The American Journal of Pathology|July 27, 2011
Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12Yusuke Kobayashi, Takatsune Shimizu, Hideaki Naoe, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2007
Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki-Miyaura coupling reactions in aqueous mediaTomohiro Maegawa, Yoshiaki Kitamura, Satoko Sako, et al.
Oncology Reports|January 8, 2013
New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review)Kiyoko Umene, Kouji Banno, Iori Kisu, et al.
The Oncologist|February 23, 2026
Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomasKaoru Fujieda, Takeo Minaguchi, Kaori Ono, et al.
The Keio Journal of Medicine|March 25, 2025
Current Situation and Future Directions of Risk-reducing Salpingo-oophorectomyKenta Masuda, Yusuke Kobayashi, Tomoko Seki, et al.
Journal of Human Genetics|July 6, 2026
Towards sustainable hereditary breast and ovarian cancer surveillance: insights from a single-center surveyYumiko Goto, Tomoko Seki, Daisuke Nakato, et al.
Pageof 38

Showing results (281-290 of 380) with videos related to

Sort By:
Pageof 38
Surgical Case Reports|May 21, 2026
Upfront Cytoreductive Surgery as a Bridge to Systemic Therapy for Recurrent Peritoneal Dissemination of Ovarian Angiosarcoma: A Pediatric Case ReportMasanaga Matsumoto, Takato Sasaki, Yudai Goto, et al.
International Journal of Clinical Oncology|October 14, 2021
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patientsNaomi Iwasa-Inoue, Hiroyuki Nomura, Fumio Kataoka, et al.
Journal of Gynecologic Oncology|June 17, 2022
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosisTakayuki Takahashi, Hikaru Matsuoka, Rieko Sakurai, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian CancerYusuke Kobayashi, Takashi Takeda, Haruko Kunitomi, et al.
The American Journal of Pathology|July 27, 2011
Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12Yusuke Kobayashi, Takatsune Shimizu, Hideaki Naoe, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2007
Heterogeneous Pd/C-catalyzed ligand-free, room-temperature Suzuki-Miyaura coupling reactions in aqueous mediaTomohiro Maegawa, Yoshiaki Kitamura, Satoko Sako, et al.
Oncology Reports|January 8, 2013
New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review)Kiyoko Umene, Kouji Banno, Iori Kisu, et al.
The Oncologist|February 23, 2026
Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomasKaoru Fujieda, Takeo Minaguchi, Kaori Ono, et al.
The Keio Journal of Medicine|March 25, 2025
Current Situation and Future Directions of Risk-reducing Salpingo-oophorectomyKenta Masuda, Yusuke Kobayashi, Tomoko Seki, et al.
Journal of Human Genetics|July 6, 2026
Towards sustainable hereditary breast and ovarian cancer surveillance: insights from a single-center surveyYumiko Goto, Tomoko Seki, Daisuke Nakato, et al.
Pageof 38